Despite this, our data showed that individuals with PSA level ≤ 4.0 ng/mL can be distinguished into cancer-free or PCa-affected based on the expression levels of OR51E2 and SIM2 genes. This evidence concerns the gene SIM2 and posterior cortical atrophy.